1-4 of 4
Rika Kihara, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development of Predictive Biomarker and Optimal Treatment Strategy with FLT3 Inhibitors in Acute Myeloid Leukemia

Jeong Hui Kim, Yasuhiko Harada, MD PhD, Yuichi Ishikawa, MD PhD, Naomi Kawashima, MD PhD, Marie Nakashima, MD, Yoko Ushijima, MD PhD, Takahiro Nishiyama, MD PhD, Tatsunori Goto, MD PhD, Nobuaki Fukushima, MD PhD, Rika Kihara, MD PhD, Tomohiro Kajiguchi, MD PhD, Koichi Watamoto, MD PhD, Akio Kohno, MD PhD, Kunio Kitamura, MD PhD, Yukiyasu Ozawa, MD PhD, Hitoshi Kiyoi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1418.
https://doi.org/10.1182/blood-2019-127610
Published: 2019
Journal Articles

Effect of Speciallist Palliative Care Service on End-of Life Care in Patients with Hematologic Malignancies

Rika Kihara, MD PhD, Yumi Ishiguri, MD, Norihiro Ueda, MD, Yasuyuki Asai, MD, Takuya Odagiri, MD, Koichi Watamoto, MD PhD, Hiroaki Watanabe, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2242.
https://doi.org/10.1182/blood-2018-99-110127
Published: 2018
Journal Articles

Dynamics of Genetic Landscapes and Clonal Evolution between Patients and PDX Models in Acute Myeloid Leukemia

Naomi Kawashima, MD, Yuichi Ishikawa, MD PhD, Akimi Akashi, MS, Hikaru Hattori, MS, Yohei Yamaguchi, MD, Takahiro Nishiyama, MD PhD, Rika Kihara, MD PhD, Yukiyasu Ozawa, Hitoshi Kiyoi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 439.
https://doi.org/10.1182/blood-2018-99-114085
Published: 2018
Journal Articles

DNMT3A and IDH1/2 Mutations Are Stable During the Progression of Acute Myeloid Leukemia

Rika Kihara, MD, Hideaki Hoshino, Hitoshi Kiyoi, MD, PhD, Tomoki Naoe, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1466.
https://doi.org/10.1182/blood.V118.21.1466.1466
Published: 2011